XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jul. 28, 2024
Jul. 30, 2023
Cash flows from operating activities:    
Net loss $ (193,454) $ (411,420)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 23,071 46,565
Amortization of right-of-use assets 3,189 3,282
Investment impairments and credit loss reserves, net 1,109 260
Goodwill impairment 0 279,555
Accretion of deferred financing costs 4,758 3,103
Write-off of deferred financing costs 5,497 771
Loss on extinguishment of debt 143,467 0
Deferred income taxes (934) 50,542
Share-based compensation 32,372 21,803
Loss (gain) on disposition of business operations and assets 91 (17)
Equity method (income) loss (50) 19
Gain from sale of investments (277) 0
Corporate-owned life insurance, net 1,670 3,212
Amortization of inventory step-up 0 3,314
Changes in assets and liabilities:    
Accounts receivable, net (18,701) 2,725
Inventories (11,031) 22,094
Other assets 3,705 (11,179)
Accounts payable 31,084 (37,730)
Accrued liabilities (26,660) (71,211)
Other liabilities (3,990) (7,680)
Net cash used in operating activities (5,084) (101,992)
Cash flows from investing activities:    
Proceeds from sales of property, plant and equipment 73 42
Purchase of property, plant and equipment (4,745) (20,897)
Proceeds from sale of investments 2,650 0
Purchase of investments (434) (930)
Purchase of intangibles (5,018) (292)
Proceeds from corporate-owned life insurance 4,802 2,500
Net cash used in investing activities (2,672) (19,577)
Cash flows from financing activities:    
Proceeds from revolving line of credit 0 60,000
Payments of term loans 0 (11,187)
Deferred financing costs (824) (11,671)
Payments for employee share-based compensation payroll taxes (4,185) (2,415)
Proceeds from exercise of stock options 643 0
Distributions to noncontrolling interest (184) 0
Net cash (used in) provided by financing activities (4,550) 34,727
Effect of foreign exchange rate changes on cash and cash equivalents (351) (756)
Net decrease in cash and cash equivalents (12,657) (87,598)
Cash and cash equivalents at beginning of period 128,585 235,510
Cash and cash equivalents at end of period 115,928 147,912
Supplemental disclosure of cash flow information:    
Interest paid 42,352 40,912
Income taxes paid 3,809 15,612
Non-cash investing and financing activities:    
Accounts payable related to capital expenditures 269 1,640
Accrued deferred financing costs 383 349
Debt extinguished in exchange for common stock $ 188,050 $ 0